Blockade of atopic dermatitis-like skin lesions by DA-9102, a natural medicine isolated from actinidia arguta, in the Mgdeficiency induced dermatitis model of hairless rats

Experimental Biology and Medicine

Volumn 233, Issue 8, 2008, Pages 1026-1034

  Choi, Jeong June ^a   Park, Bokyoung ^a   Kim, Dong Hee ^a   Pyo, Myoung Yun ^b   Choi, Sangzin ^c   Son, Miwon ^c   Jin, Mirim ^a,d  

^a Daejeon University   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c R and D Center   (South Korea)

^d Department of Pathology Daejeon University College of Oriental Medicine   (South Korea)

Author keywords

Actinidia arguta; DA 9102; Hairless rat (OFA hr hr); Immune modulator; Mg deficiency induced dermatitis

Indexed keywords

ACTINIDIA ARGUTA EXTRACT; CD11B ANTIGEN; CD45RA ANTIGEN; CYTOKINE; DA 9102; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 4; LEUKOTRIENE B4; MAGNESIUM; MESSENGER RNA; NITRIC OXIDE; PLANT EXTRACT; UNCLASSIFIED DRUG; WATER; CD45 ANTIGEN; HERBACEOUS AGENT;

ACTINIDIA ARGUTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CELL ACTIVATION; CELL INFILTRATION; CLINICAL TRIAL; CONTROLLED STUDY; DERMIS; DOSE RESPONSE; ECZEMA; EPIDERMIS; FLOW CYTOMETRY; HAIRLESS RAT; HUMAN; INFLAMMATORY CELL; LEUKOCYTE; MAGNESIUM DEFICIENCY; MALE; MEDICINAL PLANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; RAT; SCRATCHING; SKIN DEFECT; TH2 CELL; TREATMENT DURATION; WATER LOSS; ANIMAL; BLOOD; DISEASE MODEL; ISOLATION AND PURIFICATION; KIWIFRUIT; METABOLISM; PATHOLOGY; PHYTOTHERAPY;

ACTINIDIA ARGUTA; RATTUS;

ACTINIDIA; ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD45; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; IMMUNOGLOBULIN E; MAGNESIUM DEFICIENCY; MALE; PHYTOTHERAPY; RATS; RATS, HAIRLESS;

EID: 50649117140     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0801-RM-19     Document Type: Article

References (36)

1. Schmitt J, Schakel K, Schmitt N, Meurer M. Systemic treatment of severe atopic eczema: a systematic review. Acta Derm Venereol 87: 100-111, 2007.
2. Buys LM. Treatment options for atopic dermatitis. Am Fam Physician 75:523-528, 2007.
3. Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 135:1522-1525, 1999.
4. Sidbury R, Hanifin JM. Systemic therapy of atopic dermatitis. Clin Exp Dermatol 25:559-566, 2000.
5. Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, Salek MS, Graham-Brown RA, Allen BR, Camp RD. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 338:137-140, 1991.
6. Behnam SM, Behnam SE, Koo JY. Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use. J Drugs Dermatol 4:189-194, 2005.
7. Tan BB, Lear JT, Gawkrodger DJ, English JS. Azathioprine in dermatology: a survey of current practice in the U.K. Br J Dermatol 136:351-355, 1997.
8. Matich AJ, Young H, Allen JM, Wang MY, Fielder S, McNeilage MA, MacRae EA. Actinidia arguta: volatile compounds in fruit and flowers. Phytochemistry 63:285-301, 2003.
9. Webby RF. A flavonol triglycoside from Actinidia arguta var. giraldii. Phytochemistry 30:2443-2444, 1991.
10. Takano F, Tanaka T, Tsukamoto E, Yahagi N, Fushiya S. Isolation of (+)-catechin and (-)-epicatechin from Actinidia arguta as bone marrow cell proliferation promoting compounds. Planta Med 69:321-326, 2003.
11. Park EJ, Kim B, Eo H, Park K, Kim Y, Lee HJ, Son M, Chang YS, Cho SH, Kim S, Jin M. Control of IgE and selective T(H)1 and T(H)2 cytokines by PG102 isolated from Actinidia arguta. J Allergy Clin Immunol 116:1151-1157, 2005.
12. Park EJ, Park KC, Eo H, Seo J, Son M, Kim KH, Chang YS, Cho SH, Min KU, Jin M, Kim S. Suppression of spontaneous dermatitis in NC/Nga murine model by PG102 isolated from Actinidia arguta. J Invest Dermatol 127:1154-1160, 2007.
13. Claverie-Benureau S, Lebel B, Gaudin-Harding F. Magnesium deficiency allergy-like crisis in hairless rats: a suggested model for inflammation studies. J Physiol (Paris) 76:173-175, 1980.
14. Chavaz P, Faucher F, Saurat JH. Dermatosis of hairless rats fed a hypomagnesic diet-pathology and immunology. Dermatologica 169: 105-111, 1984.
15. Breuer K, Werfel T, Kapp A. Allergic manifestations of skin diseasesatopic dermatitis. Chem Immunol Allergy 91:76-86, 2006.
16. Ponvert C, Galoppin L, Saurat JH. The dermatosis of hairless rats fed a hypomagnesaemic diet. I. Course, clinical features and inhibition by drugs. Clin Exp Dermatol 8:539-547, 1983.
17. Alcock NW, Shils ME, Lieberman PH, Erlandson RA. Thymic changes in the magnesium-depleted rat. Cancer Res 33:2196-2204, 1973.
18. Mease AD. Letter: carcinogenic potential of magnesium deficiency. Lancet 2:590, 1974.
19. Kraeuter SL, Schwartz R. Blood and mast cell histamine levels in magnesium-deficient rats. J Nutr 110:851-858, 1980.
20. Hungerford GF. Role of histamine in producing the eosinophilia of magnesium deficiency. Proc Soc Exp Biol Med 115:182-185, 1964.
21. Rock E, Astier C, Lab C, Malpuech C, Nowacki W, Gueux E, Mazur A, Rayssiguier Y. Magnesium deficiency in rats induces a rise in plasma nitric oxide. Magnes Res 8:237-242, 1995.
22. Weglicki WB, Phillips TM, Freedman AM, Cassidy MM, Dickens BF. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 110:169-173, 1992.
23. Mak IT, Komarov AM, Wagner TL, Stafford RE, Dickens BF, Weglicki WB. Enhanced NO production during Mg deficiency and its role in mediating red blood cell glutathione loss. Am J Physiol 271: C385-390, 1996.
24. Hanada K, Mitsuhashi Y, Hashimoto I. Inhibitory effect of the leukotriene B4 receptor antagonist against hypomagnesic diet-induced dermatitis in hairless rats. J Dermatol 19:456-460, 1992.
25. Leung DY. Atopic dermatitis: immunobiology and treatment with immune modulators. Clin Exp Immunol 107 Suppl 1:25-30, 1997.
26. Denda M, Tsuchiya T, Hosoi J, Koyama J. Immobilization-induced and crowded environment-induced stress delay barrier recovery in murine skin. Br J Dermatol 138:780-785, 1998.
27. Maeng HG, Kim DN, Cho SK, Cha JH, Kim TY, Lee YS, Choi DK, Lee JH, Cho MJ, Kwon HJ, Lee SK. Altered immune cell proportions in the radiodermatitis induced hairless mice-1 (HR-1). J Radiat Res (Tokyo) 47:9-17, 2006.
28. Woollett GR, Barclay AN, Puklavec M, Williams AF. Molecular and antigenic heterogeneity of the rat leukocyte-common antigen from thymocytes and T and B lymphocytes. Eur J Immunol 15:168-173, 1985.
29. Tamatani T, Kitamura F, Kuida K, Shirao M, Mochizuki M, Suematsu M, Schmid-Schonbein GW, Watanabe K, Tsurufuji S, Miyasaka M. Characterization of rat LECAM-1 (L-selectin) by the use of monoclonal antibodies and evidence for the presence of soluble LECAM-1 in rat sera. Eur J Immunol 23:2181-2188, 1993.
30. Holden CA. Parish WE. Atopic Dermatitis. Oxford: Blackwell Science, pp681-708, 1998.
31. Dadfar E, Jacobson SH, Lundahl J. Newly recruited human monocytes have a preserved responsiveness towards bacterial peptides in terms of CD11b up-regulation and intracellular hydrogen peroxide production. Clin Exp Immunol 148:573-582, 2007.
32. Yamada H, Kurashimo S, Chihara J, Matsukura M, Yudate T, Tezuka T. Overexpression of CD11b on eosinophils in atopic dermatitis: downregulation by cyclosporin A and upregulation by interleukin 5. Int Arch Allergy Immunol 120 (Suppl 1):100-103, 1999.
33. Montes CL, Acosta-Rodriguez EV, Mucci J, Zuniga EI, Campetella O, Gruppi A. A Trypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells. Eur J Immunol 36:1474-1485, 2006.
34. Taniuchi S, Kojima T, Hara Mt K, Yamamoto A, Sasai M, Takahashi H, Kobayashi Y. Increased serum nitrate levels in infants with atopic dermatitis. Allergy 56:693-695, 2001.
35. Oymar K, Aksnes L. Increased levels of urinary leukotriene E4 in children with severe atopic eczema/dermatitis syndrome. Allergy 60: 86-89, 2005.
36. Daniels J, Harper J. The epidemiology of atopic dermatitis. Hosp Med 63:649-652, 2002.